Theravance Inc (NASDAQ:THRX)
| 21.70 Data as of Jul 31 |  -0.25 / -1.14%Today’s Change | 20.23 Today|||52-Week Range 34.52 | -24.44% Year-to-Date |
Latest THRX News | Press Releases
Today’s Trading
| Previous close | 21.95 |
| Today’s open | 21.57 |
| Day’s range | 21.26 - 21.90 |
| Volume | 788,024 |
| Average volume (3 months) | 1,253,460 |
| Market cap | $2.4B |
| Dividend yield | -- |
Data as of 07/31/2014
Growth & Valuation
| Earnings growth (last year) | -735.00% |
| Earnings growth (this year) | +29.22% |
| Earnings growth (next 5 years) | +3.00% |
| Revenue growth (last year) | -96.50% |
| P/E ratio | NM |
| Price/Sales | 767.43 |
| Price/Book | 8.09 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| WXWuXi Pharmatech (Cay... | -0.99 | -3.11% |
| MYGNMyriad Genetics Inc | -0.62 | -1.69% |
| IRWDIronwood Pharmaceuti... | -0.42 | -2.76% |
| ACADACADIA Pharmaceutica... | -0.94 | -4.43% |
Data as of 07/31/2014
Financials
| Next reporting date | October 23, 2014 |
| EPS forecast (this quarter) | -$0.05 |
| Annual revenue (last year) | $4.8M |
| Annual profit (last year) | -$170.7M |
| Net profit margin | -3,587.66% |
Profile
Sector Health Technology |
Industry Biotechnology |
Chairman, President & Chief Executive Officer Rick E. Winningham |
Senior Vice President- Operations Frank C. Pasqualone |
Corporate headquarters South San Francisco, California |
Forecasts
.
